fiveBelow Inc. diskutieren
fiveBelow Inc.
WKN: A1JZ18 / Symbol: FIVE / Name: fiveBelow / Aktie / Einzelhandel / Mid Cap /
72,34 €
4,12 %
Five Below, Inc. (NASDAQ: FIVE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its "outperform" rating re-affirmed by analysts at Telsey Advisory Group. They now have a $230.00 price target on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its "outperform" rating re-affirmed by analysts at Telsey Advisory Group. They now have a $225.00 price target on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target lowered by analysts at Craig Hallum from $224.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target lowered by analysts at Telsey Advisory Group from $225.00 to $220.00. They now have an "outperform" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $220.00 price target on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target lowered by analysts at Truist Financial Co. from $201.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its "outperform" rating re-affirmed by analysts at Telsey Advisory Group. They now have a $220.00 price target on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at Citigroup Inc. from $220.00 to $227.00. They now have a "buy" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at Wells Fargo & Company from $205.00 to $215.00. They now have an "overweight" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at Morgan Stanley from $210.00 to $225.00. They now have an "overweight" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at JPMorgan Chase & Co. from $210.00 to $212.00. They now have an "overweight" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at Truist Financial Co. from $195.00 to $214.00. They now have a "buy" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $245.00 price target on the stock, up previously from $215.00.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at Barclays PLC from $219.00 to $236.00. They now have an "overweight" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target lowered by analysts at Telsey Advisory Group from $235.00 to $230.00. They now have an "outperform" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target raised by analysts at JPMorgan Chase & Co. from $217.00 to $222.00. They now have an "overweight" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target lowered by analysts at JPMorgan Chase & Co. from $222.00 to $215.00. They now have an "overweight" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Five Below, Inc. (NASDAQ: FIVE) had its price target lowered by analysts at Telsey Advisory Group from $230.00 to $220.00. They now have an "outperform" rating on the stock.
Ratings data for FIVE provided by MarketBeat
Neueste Beiträge
Stifel_Nicolaus in BioMarin Pharmaceutical Inc. diskutieren